期刊文献+

多囊卵巢综合征患者的胰岛素抵抗临床特征及相关因素分析 被引量:29

Analysis on clinical characteristics and related factors of insulin resistance of polycystic ovary syndrome
原文传递
导出
摘要 目的探讨多囊卵巢综合征患者的胰岛素抵抗的临床特征,并对影响因素进行相关性分析。方法分析76例接受治疗的多囊卵巢综合征患者的临床资料,将40例胰岛素抵抗的患者作为观察组,选取36例非胰岛素抵抗的患者作为对照组。比较两组血脂水平、激素水平、葡萄糖耐量、胰岛素抵抗指数及其与BMI、GAUC的相关性。结果观察组患者体质指数水平明显高于对照组(χ2=3.499,P=0.001);观察组患者TG(t=5.980,P<0.001)、HDL(t=7.812,P<0.001)水平显著高于对照组;两组研究对象TC(t=1.386,P=0.170)和LDL(t=1.851,P=0.068)水平差异不明显;两组孕酮(P)、睾酮(T)、雌二醇(E2)、催乳素(PRL)、黄体生成素(LH)、卵泡刺激素(FSH)水平比较,差异无统计学意义(P>0.05);观察组FPG(t=2.225,P=0.029)、FINS(t=5.668,P<0.001)、GAUC(t=5.017,P<0.001)、HOMA-IR(t=5.087,P<0.001)水平明显高于对照组;PCOS胰岛素抵抗患者HOMA-IR与BMI(r=0.549,P<0.001)、GAUC(r=0.549,P<0.001)呈显著的正相关。结论 PCOS胰岛素抵抗患者HOMA-IR与BMI、GAUC呈现显著的正相关关系,肥胖和葡萄糖耐量的降低可以增加PCOS胰岛素抵抗患者的发病风险。 Objective To explore the clinical characteristics of insulin resistance of polycystic ovary syndrome( PCOS),analyze the correlation of influencing factors. Methods The clinical data of 76 PCOS patients treated in the hospital was analyzed,then the cases were divided into observation group( 40 cases with insulin resistance) and control group( 36 cases without insulin resistance). The levels of blood lipids,hormones,glucose tolerance,insulin resistance indexes in the two groups were compared,their correlations with body mass index( BMI) and GAUC were analyzed. Results BMI in observation group was statistically significantly higher than that in control group( χ^2= 3. 499,P = 0. 001); the levels of triglyceride( TG) and high-density lipoprotein( HDL) in observation group were statistically significantly higher than those in control group( t = 5. 980,P〈0.001; t = 7. 812,P〈0.001); there was no statistically significant difference in the levels of total cholesterol( TC) and low-density lipoprotein( LDL) between the two groups( t = 1. 386,P = 0. 170; t = 1. 851,P = 0. 068);there was no statistically significant difference in the levels of progesterone( P),testosterone( T),estradiol( E2),prolactin( PRL),luteinizing hormone( LH),follicle-stimulating hormone( FSH) between the two groups( P〉0. 05); fasting plasma glucose( FPG) level,fasting insulin( FINS) level,GAUC,and HOMA-IR in observation group were statistically significantly higher than those in control group( t =2. 225,P = 0. 029; t = 5. 668,P〈0.001; t = 5. 017,P〈0.001; t = 5. 087,P〈0.001); in observation group,HOMA-IR was significantly positively correlated with BMI( r = 0. 549,P〈0.001) and GAUC( r = 0. 549,P〈0.001). Conclusion HOMA-IR is significantly positively correlated with BMI and GAUC in PCOS patients with insulin resistance,obesity and decrease of glucose tolerance can increase the risk of PCOS patients with insulin resistance.
出处 《中国妇幼保健》 CAS 2016年第6期1147-1149,共3页 Maternal and Child Health Care of China
关键词 多囊卵巢综合征 胰岛素抵抗 葡萄糖耐量试验 Polycystic ovary syndrome Insulin resistance Oral glucose tolerance test
  • 相关文献

参考文献10

二级参考文献40

  • 1杨冬梓,陈晓莉.PCOS胰岛素抵抗的检测和评估[J].实用妇产科杂志,2005,21(9):515-517. 被引量:8
  • 2李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:137
  • 3Azgig B. Polycystlc ovary syndrome, insulin resistance, and molecular defects of insulin signaling EJ]. J Clin Endocrinol Metal), 2002, 87(9) : 4085 -4087.
  • 4The Rotterdam ESHRE/ASRM - Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long - term health risks related ~ polycystic ovary syndrome [ J]. Fertility and Ste- rility, 2004, 81 (1): 19 -25.
  • 5Otto C, Otto B, Coke B, et al. Increase in adiponecfin levels during pioglitazone therapy in relation to glucose control, insulin resistanee as well as ghrelin and resist in levels [ J ]. J Endocrinal Invest, 2006, 29(3) : 231 -236.
  • 6Caro J. Cellular alteration in liver, skeletal muscle and adipotissue re- sponsible for insulin resistance in obesity and type 2 diabetes [ J]. Dia- betes Metab Rev, 1989, 5: 655.
  • 7WaUdius G, Jungner I, Aastveit AH, et al. The apoB/apoA- I ra- tio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and atiatherogenic lipopmteins and to predict cor- onary risk [J]. Clin (]hem Lab Med, 2004, 42: 1355.
  • 8Tsilchorozidou T, Overton G, Gonway GS. The pathophysiology of polycystic ovary syndrome [ J]. Clin Endocrlnot (OxJ), 2004, 60: 1 - 17.
  • 9Dunaif A, Green G, Phelps RG, et al. Acanthosis nigricans, insu- lin action, and hyperandrogenism: clinical, histological, and bio- chemical findings EJ]. J Clin Endocrinol Metab, 1991, 73:590 - 595.
  • 10Kravarlti M, Naka KK, Kalantaridou SN, et al. Predictors d endo- thelial dysfunction in young women with polycystic ovary syndrome EJ]. J Clin Endocrinol Metab, 2005, 90:5088 -5095.

共引文献33

同被引文献279

引证文献29

二级引证文献262

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部